Literature DB >> 17720524

Obesity and hemodialysis vascular access failure.

Troy J Plumb1, Anthony B Adelson, Gerald C Groggel, Jason M Johanning, Thomas G Lynch, Bryce Lund.   

Abstract

A variety of factors have been proposed to explain arteriovenous fistula primary failures in patients undergoing hemodialysis, including obesity, diabetes mellitus, female sex, and the absence of preoperative vein mapping. In this report, we describe 2 women for whom premature upper-extremity arteriovenous fistula failures occurred in the setting of venographic evidence of soft-tissue compression of the venous outflow with the patient's arm in the adducted position. In each instance, preoperative noninvasive duplex vein mapping showed veins of adequate diameter (0.28 to 0.54 cm), and further evaluation showed no evidence of a hypercoagulable state. Upper-extremity venography was used to assess central venous patency and fully assess the venous vasculature. Unlike the widely patent venous systems seen in the abducted position, venography performed with the upper extremities in adduction showed marked narrowing of the brachial and/or axillary veins. The hemodynamic effects of this narrowing were readily apparent in patient 2 with the appearance of collateral filling of the cephalic vein in the adducted position. Patient 1 had a body mass index of 39 kg/m(2), and patient 2 had a body mass index of 34 kg/m(2). Each patient had excess axillary soft tissue that appeared to compress the venous outflow in adduction. To our knowledge, this is the first report to radiographically document soft-tissue compression of the venous outflow of the upper extremity in the adducted position, suggesting a mechanism whereby obesity, or at least excess axillary fat, can lead to premature hemodialysis vascular access failures.

Entities:  

Mesh:

Year:  2007        PMID: 17720524     DOI: 10.1053/j.ajkd.2007.06.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

1.  Association of Permanent Vascular Access Dysfunction with Subsequent Risk of Cardiovascular Disease: A Population-Based Cohort Study.

Authors:  Tung-Wei Hung; Sheng-Wen Wu; Jeng-Yuan Chiou; Yu-Hsun Wang; Yu-Chan Liao; Cheng-Chung Wei
Journal:  J Pers Med       Date:  2022-04-08

2.  The association of endothelial progenitor cell markers with arteriovenous fistula maturation in hemodialysis patients.

Authors:  Eray Eroglu; Ismail Kocyigit; Berkay Saraymen; Aydin Tuncay; Ertugrul Mavili; Aydin Unal; Huseyin Avcilar; Mustafa Yavuz Koker; Oktay Oymak
Journal:  Int Urol Nephrol       Date:  2016-04-11       Impact factor: 2.370

Review 3.  Management of Obesity in Adults with CKD.

Authors:  Allon N Friedman; Lee M Kaplan; Carel W le Roux; Philip R Schauer
Journal:  J Am Soc Nephrol       Date:  2021-02-18       Impact factor: 10.121

4.  The outcome of the primary vascular access and its translation into prevalent access use rates in chronic haemodialysis patients.

Authors:  Claudia Praehauser; Tobias Breidthardt; Cora Nina Moser-Bucher; Thomas Wolff; Katrin Baechler; Thomas Eugster; Michael Dickenmann; Lorenz Gurke; Michael Mayr
Journal:  Clin Kidney J       Date:  2012-06-28

5.  Association Between Vascular Access Dysfunction and Subsequent Major Adverse Cardiovascular Events in Patients on Hemodialysis: A Population-Based Nested Case-Control Study.

Authors:  Te-Hui Kuo; Chien-Tzu Tseng; Wei-Hung Lin; Jo-Yen Chao; Wei-Ming Wang; Chung-Yi Li; Ming-Cheng Wang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

6.  Features of atherosclerosis in hemodialysis patients.

Authors:  Kyong Ah Park; Hye Min Jo; Ji Soo Han; Min Jin Kim; Do Hyung Kwun; Moo Yong Park; Soo Jeong Choi; Jin Kuk Kim; Seung Duk Hwang
Journal:  Kidney Res Clin Pract       Date:  2013-11-25

7.  Population-based Trends in Obesity and Kidney Transplantation Among Patients With End-stage Kidney Disease.

Authors:  Glenn K Wakam; Kyle H Sheetz; Laura Gerhardinger; John R Montgomery; Seth A Waits
Journal:  Transplant Direct       Date:  2021-11-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.